Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cognition Therapeutics Inc (CGTX)

Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cognition Therapeutics Inc 2500 WESTCHESTER AVENUE PURCHASE NY 10577 USA

www.cogrx.com Employees: 28 P: 412-481-2210

Description:

Cognition Therapeutics Inc.is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Cognition Therapeutics Inc.is based in PURCHASE, N.Y.

Key Statistics

Overview:

Market Capitalization, $K 18,281
Enterprise Value, $K -11,639
Shares Outstanding, K 41,548
Annual Sales, $ 0 K
Annual Net Income, $ -25,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,940 K
EBIT, $ -58,430 K
EBITDA, $ -58,180 K
60-Month Beta 1.34
% of Insider Shareholders 20.75%
% of Institutional Shareholders 43.35%
Float, K 32,927
% Float 79.25%
Short Volume Ratio 0.29

Growth:

1-Year Return -56.00%
3-Year Return -95.07%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 11/13/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -0.97
EPS Growth vs. Prev Qtr -38.89%
EPS Growth vs. Prev Year -13.64%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CGTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -150.93%
Return-on-Assets % -100.82%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.23
Book Value/Share 0.36
Interest Coverage -858.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar